Morrison B E, Majdzadeh N, D'Mello S R
Department of Molecular and Cell Biology, University of Texas at Dallas, 2601 N. Floyd Rd., Richardson, TX 75080, USA.
Cell Mol Life Sci. 2007 Sep;64(17):2258-69. doi: 10.1007/s00018-007-7035-9.
Neurodegenerative disease strikes millions worldwide and there is mounting evidence suggesting that underlying the onset and progression of these debilitating diseases is inappropriate neuronal apoptosis. Recent reports have implicated a family of proteins known as histone deacetylases (HDACs) in various neuronal processes including the neuronal death program. Initial headway in this field has been made largely through the use of broad-spectrum HDAC inhibitors. In fact, pharmacological inhibition of HDAC activity has been shown to protect neurons in several models of neurodegeneration. The observation that HDAC inhibitors can have opposing effects in different paradigms of neurodegeneration suggests that individual members of the HDAC protein family may play distinct roles that could depend on the specific cell type under study. The purpose of this review is to detail work involving the use of HDAC inhibitors within the context of neurodegeneration and examine the roles of individual HDAC members in the nervous system with specific focus on neuronal cell death.
神经退行性疾病在全球范围内影响着数百万人,越来越多的证据表明,这些使人衰弱的疾病的发病和进展是由不适当的神经元凋亡引起的。最近的报道表明,一类名为组蛋白脱乙酰酶(HDACs)的蛋白质参与了包括神经元死亡程序在内的各种神经元过程。该领域的初步进展主要是通过使用广谱HDAC抑制剂取得的。事实上,在几种神经退行性疾病模型中,HDAC活性的药理抑制已被证明可以保护神经元。HDAC抑制剂在不同的神经退行性疾病模型中可能产生相反的作用,这一观察结果表明,HDAC蛋白家族的各个成员可能发挥不同的作用,这可能取决于所研究的特定细胞类型。这篇综述的目的是详细介绍在神经退行性疾病背景下使用HDAC抑制剂的相关研究,并研究HDAC各个成员在神经系统中的作用,特别关注神经元细胞死亡。